TBP — Tetra Bio Pharma Share News
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
Brief: Tetra Bio Pharma Confirms FDA Meeting Date Regarding Hcc011
Brief: Tetra Bio Pharma Announces Filing Of Final Base Shelf Prospectus For Up To $50 Mln Of Securities
Brief: Tetra Biopharma Survey Validates Primary Endpoint Of Serenity Clinical Trial
Brief: Tetra Bio-Pharma Announces Exercise Of Over-Allotment Option In Connection With Bought Deal Financing
Development Agreement With Makscientific
Brief: Tetra Bio-Pharma Provides Additional Information On Qixleef Following Letter Of Advice & Type B Meeting With U.S. FDA
Brief: Tetra Bio-Pharma Initiates A Proof Of Concept Clinical Trial For Its Ophthalmic Drug In Dogs
Brief: Tetra Bio-Pharma Receives Favorable Response Following Type B Meeting With U.S. FDA For CAUMZ
Brief: Tetra Bio-Pharma Announces Upsizing Of Previously Announced Offering
Brief: Tetra Bio-Pharma Announces $10 Mln Bought Deal Offering
Brief: Tetra Bio-Pharma Provides Update On Commercialization Plan For Its OTC DIN And NHP Product Programs
Brief: Tetra Bio-Pharma Granted Two OTC Drug Identification Numbers By Health Canada
Brief: Tetra Bio-Pharma Receives Favorable Letter Of Advice From Usa FDA For Qixleef
Brief: Tetra Bio Pharma Says Submitted Data To U.S. FDA For Surrogate Endpoint To Be Used For An Accelerated Approval For Caumz
Brief: Tetra Bio-Pharma Signs Definitive Commercialization Agreement For Caumz In Portugal With Azevedos Indústria Farmacêutica, S.A
Brief: Tetra Bio-Pharma Provides Update On Its Hepatocellular Carcinoma Drug
Brief: Tetra Bio-Pharma Receives FDA Orphan Drug Designation For Hepatocellular Carcinoma
Brief: Tetra Bio-Pharma Signs Definitive Commercialization Agreement For Caumz In Mexico With Alternavida S.A.
Brief: Tetra Natural Health Submitted 2 Over-The-Counter Din Applications To Health Canada